Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Carol Burke, M.D.
The Cleveland Clinic
Principal Investigator - Gabriella Möslein, M.D.
Helios Hospital
Principal Investigator - James Church, M.D.
The Cleveland Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Uz Leuven
Leuven, Belgium
- Zane Cohen Centre for Digestive Diseases
Toronto, Ontario, Canada
- University Hospital Bonn
Bonn, Germany
- Academic Medical Centre
Amsterdam, Netherlands
- Institut de Malalties Digestives
Barcelona, Catalonia, Spain
- Institute of Genetic Medicine
Newcastle upon Tyne, Tyne and Wear, United Kingdom
- Manchester Center for Genomic Medicine
Manchester, United Kingdom
- University of California San Diego
La Jolla, California, United States
- Emory University
Atlanta, Georgia, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- University of Utah- Huntsman Cancer Institute
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2013
- Primary completion
- 30 Nov 2018
- Completion
- 31 Mar 2019
- Last update posted
- 8 Jun 2021
- Registered enrollment
- 171
- Registry id
- NCT01483144
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.